Buscar resultados de ensayos clínicos
Chromosome 17p Deletion - 14 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion Condición:
|
Terminated |
Nombre del estudio: Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion Condición: B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion Fecha: 2014-01-22 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion Condición:
Fecha: 2014-11-19 Intervenciones:
|
Recruiting |
Nombre del estudio: Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL Condición:
Fecha: 2011-10-18 Intervenciones:
|
Recruiting |
Nombre del estudio: Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine Condición: Chronic Lymphocytic Leukemia Fecha: 2011-06-28 Intervenciones: Drug: Alemtuzumab Alemtuzumab 30 mg s.c. 3 × weekly for 28 days (Days 1, 3, 5; 8, 10, 12; etc.) |
Recruiting |
Nombre del estudio: A Study Evaluating Venetoclax in Subjects With Chronic Lymphocytic Leukemia Whose Cancer Has Come Back or Who Had No Response to Previous Cancer Treatments Including Subjects Missing Part of Their Chromosome 17, or TP53 Gene Mutation; or Who Received Prior Treatment With a B-Cell Receptor Inhibitor Condición: Chronic Lymphocytic Leukemia (CLL) Fecha: 2016-11-30 Intervenciones: Drug: Venetoclax Tablet Other Name: ABT-199 |
Completed |
Nombre del estudio: Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia Condición: Chronic Lymphocytic Leukemia Fecha: 2013-12-03 Intervenciones: Drug: Ruxolitinib 20 mg orally on day 1 to 21 of each 28 day cycle. Number of Cycles: 7 or until progres |